RHYTHM PHARMACEUTICALS INC (RYTM) Stock Income Statement
NASDAQ:RYTM - Nasdaq - US76243J1051 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 130.13M | 77.43M | 23.64M | 3.15M | 0.00 | |||
| Cost Of Goods | 13.37M | 9.30M | 2.13M | 600.00K | N/A | |||
| Gross Profit | 116.76M | 68.13M | 21.51M | 2.56M | N/A | |||
| Operating Expenses | 382.26M | 252.48M | 200.67M | 172.61M | 136.58M | |||
| Research and Development | 237.96M | 134.95M | 108.63M | 104.13M | 90.45M | |||
| Selling, General, and Administrative Expenses | 144.30M | 117.53M | 92.03M | 68.49M | 46.13M | |||
| Operating Income | -265.50M | -184.36M | -179.16M | -170.06M | -136.58M | |||
| Interest Income/Expense | 3.01M | 53.00K | -1.17M | 450.00K | 2.58M | |||
| Other Income/Expense | 2.24M | 190.00K | -790.00K | 100.00M | N/A | |||
| Income Before Taxes | -260.26M | -184.11M | -181.12M | -69.61M | -134.00M | |||
| Income Tax | 346.00K | 564.00K | N/A | 0.00 | N/A | |||
| Net Income | -264.57M | -184.68M | -181.12M | -69.61M | -134.00M | |||
| EBITDA | -263.94M | -182.60M | -177.49M | -168.90M | -135.89M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -4.34 | -3.20 | -3.47 | -1.40 | -3.04 | |||
| Non GAAP EPS | -4.49 | -3.20 | -3.48 | -3.41 | -3.05 | |||
| Statistics | ||||||||
| Gross Profit Margin | 89.73% | 87.99% | 90.99% | 81.27% | N/A | |||
| Profit Margin | -203.32% | -238.52% | -766.16% | -2209.84% | N/A | |||
| Operating Profit Margin | -204.04% | -238.10% | -757.87% | -5398.73% | N/A | |||
All data in USD